National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population

被引:54
作者
Yoshizawa, H
Tanaka, J
Miyakawa, Y
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Epidemiol Infect Dis Control & Prevent, Minami Ku, Hiroshima 7348551, Japan
[2] Miyakawa Mem Res Fdn, Tokyo, Japan
关键词
chronic hepatitis; cirrhosis; epidemiology; hepatitis C virus; hepatocellular carcinoma; prevention; transfusion;
D O I
10.1159/000087257
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During the past 30 years, hepatocellular carcinoma (HCC) in Japan has kept linearly increasing from 10 to 30 per 100,000 population per year and is expected to grow further. The increment is attributed to infection with hepatitis C virus (HCV). Hence, there is a pressing need to find subjects with persistent HCV infection in the general population of Japan and take necessary measures to prevent HCC developing in them. As a first approach toward this goal, the sex- and age-specific prevalence of ongoing HCV infection was surveyed in 3,485,648 first-time blood donors during 1995-2000. Taking into account the size of subpopulations with different sex and age in Japan registered at the Census 2000, there are an estimated 884,954 HCV carriers aged from 16 to 69 years, and 759,316 (86%) of them are older than 40 years, with an increased risk for HCC; they are hidden in the society, without overt liver disease. The national 5-year project searching for HCV carriers in the general population was started in April 2002. Subjects are examinees of health check-ups, which they receive every 5 years when reaching the age of 40, as well as those at increased risk for HCV infection. The project detected HCV RNA in 14,672 of the 1,298,746 (1.1%) health check examinees and in 16,721 of the 624,734 (2.7%) high-risk individuals during the first fiscal year. Subjects found with HCV RNA have been referred to clinics and hospitals with expert hepatologists. Hopefully, this project will decrease HCC development in HCV carriers in Japan and be considered in other countries where increases in HCC are predicted from the current age-specific prevalence of anti-HCV. Copyright (C) 2006 S. Karger AG, Basel.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 22 条
[11]   Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin [J].
Kenny-Walsh, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) :1228-1233
[12]   INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS [J].
KIYOSAWA, K ;
SODEYAMA, T ;
TANAKA, E ;
GIBO, Y ;
YOSHIZAWA, K ;
NAKANO, Y ;
FURUTA, S ;
AKAHANE, Y ;
NISHIOKA, K ;
PURCELL, RH ;
ALTER, HJ .
HEPATOLOGY, 1990, 12 (04) :671-675
[13]   Medical progress - Hepatitis B virus infection [J].
Lee, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1733-1745
[14]   Natural history of chronic hepatitis C [J].
Seeff, LB .
HEPATOLOGY, 2002, 36 (05) :S35-S46
[15]   HEPATITIS-B VACCINE - DEMONSTRATION OF EFFICACY IN A CONTROLLED CLINICAL-TRIAL IN A HIGH-RISK POPULATION IN THE UNITED-STATES [J].
SZMUNESS, W ;
STEVENS, CE ;
HARLEY, EJ ;
ZANG, EA ;
OLESZKO, WR ;
WILLIAM, DC ;
SADOVSKY, R ;
MORRISON, JM ;
KELLNER, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (15) :833-841
[16]   Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000 [J].
Tanaka, J ;
Kumagai, J ;
Katayama, K ;
Komiya, Y ;
Mizui, M ;
Yamanaka, R ;
Suzuki, K ;
Miyakawa, Y ;
Yoshizawa, H .
INTERVIROLOGY, 2004, 47 (01) :32-40
[17]   Natural histories of hepatitis C virus infection in men and women simulated by the Markov model [J].
Tanaka, J ;
Kumada, H ;
Ikeda, K ;
Chayama, K ;
Mizui, M ;
Hino, K ;
Katayama, K ;
Kumagai, J ;
Komiya, Y ;
Miyakawa, Y ;
Yoshizawa, H .
JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) :378-386
[18]   Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan [J].
Tanaka, Y ;
Hanada, K ;
Orito, E ;
Akahane, Y ;
Chayama, K ;
Yoshizawa, H ;
Sata, M ;
Ohta, N ;
Miyakawa, Y ;
Gojobori, T ;
Mizokami, M .
JOURNAL OF HEPATOLOGY, 2005, 42 (01) :47-53
[19]   CLINICAL OUTCOMES AFTER TRANSFUSION-ASSOCIATED HEPATITIS-C [J].
TONG, MJ ;
ELFARRA, NS ;
REIKES, AR ;
CO, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1463-1466
[20]   Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening [J].
Vogt, M ;
Lang, T ;
Frösner, G ;
Klingler, C ;
Sendl, AF ;
Zeller, A ;
Wiebecke, B ;
Langer, B ;
Meisner, H ;
Hess, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (12) :866-870